Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Vitamin d, determinant of bone and extrabone health . Import ance of vitamin d supplementation in milk and dairy products].
The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis.
[The impact of the vitamin D in neurological diseases and neurorehabilitation: from demencia to multiple sclerosis. Part I: the role of the vitamin D in the prevetion and treatment of multiple sclerosis].
Coping and its importance for quality of life in patients with multiple sclerosis.
Epistatic effects on the phenotype of multiple sclerosis.
Effects of walking direction and cognitive challenges on gait in persons with multiple sclerosis.
Morphologic features of the binucleated lymphocytes for the assesment of persistent B-cell polyclonal lymphocytosis.
Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients.
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.
Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.
Neurosarcoidosis: Clinical manifestations, diagnosis and treatment.
Diagnostic value of visual evoked potentials for clinical diagnosis of multiple sclerosis.
Interleukin 6 Receptor Blockade in Patients With Neuromyelitis Optica Nonresponsive to Anti-CD20 Therapy.
Prediction of MS disability by multimodal evoked potentials: Investigation during relapse or in the relapse-free interval?
Elevation of 20-carbon long chain bases due to a mutation in serine palmitoyltransferase small subunit b results in neurodegeneration.
Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.
Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial.
Need for differentiation of real and clinical important change in research on responsiveness of walking outcome measures in multiple sclerosis.
Comparing long-term results of PASAT and SDMT scores in relation to neuropsychological testing in multiple sclerosis.
Editorial Comments: Is multiple sclerosis a neurodegenerative or inflammatory disease?
Different Mechanisms of Inflammation Induced in Virus and Autoimmune-Mediated Models of Multiple Sclerosis in C57BL6 Mice.
Possible role of human herpesvirus 6 as a trigger of autoimmune disease.
Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports.
Pages
« first
‹ previous
…
682
683
684
685
686
687
688
689
690
…
next ›
last »